Scientists from Yale School of Medicine are calling on willing participants for one of two clinical trials for pharmaceutical treatments against Alzheimer’s disease, which until this day, scientists have yet to find a cure for. The only drugs available on the market today are…
Hannink and Jasmer discovered a molecule that treats oxidative stress. Credit: Randy Mertens, CAFNR A new molecule capable of fighting oxidative stress, with high potential to be developed into a drug in pill form, has been identified by researchers at the University of Missouri (MU). This…
According to researchers, moody, jealous women in mid-life may in fact face a higher risk of developing Alzheimer’s late in life. A new study entitled “Midlife personality and risk of Alzheimer disease and distress” published in the journal Neurology suggests that an increased risk to…
The National Institutes of Health has announced its first wave of investments totaling $46 million in fiscal year ’14 funds to support the goals of the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative. The funding will enable more than 100 investigators in 15 states and several countries…
Another protein was recently identified as being involved in Alzheimer’s disease by researchers at the Gladstone Institutes in California. Progranulin, a protein in the brain, can lead to amyloid-beta plaque formation when its levels are depleted. “This is the first study providing evidence for a protective role of progranulin in…
Charles Fipke, left, with Fipke Professor in Alzheimer’s Research Haakon Nygaard. Photo: Brian Kladko, UBC Charles Fipke, a Canadian geologist whose discoveries made his country one of the leading diamond producers in the world, donated $9.1 million to fund the research and treatment of Alzheimer’s disease currently being…
A group of researchers have recently discovered Alzheimer’s patients’ unusual ability to retain emotion despite memory loss. According to the findings of their study, which is now available in the September 2014 issue of Cognitive and Behavioral Neurology, patients with Alzheimer’s disease may not remember…
A new study entitled “Aromatic-turmerone induces neural stem cell proliferation in vitro and in vivo” published in September issue of Stem Cell Research & Therapy suggests Curcuma long active element Aromatic turmerone induces neural stem cells’ (NSCs) proliferation and differentiation in vivo, a key event for overcoming…
A Boston-based private biotech company has revealed it has begun the first-in-human clinical trial for one of their leading pipeline products for Alzheimer’s disease — the most common form of dementia that affects over 5 million Americans today, and is the cause of more than 500,000 deaths among older…
Patients who claim to suffer memory loss may in fact be experiencing the first symptoms of Alzheimer’s disease and may come to suffer from clinical memory impairment years later, according to a recent research conducted at the University of Kentucky’s Sanders-Brown Center on Aging. The study confirmed the importance…
Get regular updates to your inbox.